These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9232728)

  • 1. Pharmacological therapy of Helicobacter pylori infection.
    Hoffman JS
    Semin Gastrointest Dis; 1997 Jul; 8(3):156-63. PubMed ID: 9232728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
    Hoshiya S; Watanabe K; Tokunaga K; Tanaka A; Ninomiya H; Shingaki M; Itoh T; Saito S; Ishida H; Takahashi S
    J Gastroenterol; 2000; 35(1):10-4. PubMed ID: 10632534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cause of failure of eradication treatment of Helicobacter pylori].
    Chen G; Takeuchi Y; Kikuchi R; Arai D; Fukuchi K; Gomi K
    Rinsho Byori; 2005 Aug; 53(8):692-7. PubMed ID: 16190353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
    Fennerty MB
    Am J Gastroenterol; 1998 Jan; 93(1):2-3. PubMed ID: 9448162
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
    J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection.
    Trevisani L; Sartori S; Caselli M; Ruina M; Verdianelli G; Abbasciano V
    Am J Gastroenterol; 1998 Mar; 93(3):390-3. PubMed ID: 9517646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Helicobacter pylori infection.
    Miehlke S; Bayerdörffer E; Graham DY
    Semin Gastrointest Dis; 2001 Jul; 12(3):167-79. PubMed ID: 11478749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [First line therapy for Helicobacter pylori eradication in France].
    Dupas JL
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):467-72. PubMed ID: 12700504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
    Maconi G; Parente F; Russo A; Vago L; Imbesi V; Bianchi Porro G
    Am J Gastroenterol; 2001 Feb; 96(2):359-66. PubMed ID: 11232676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.
    Hunt RH
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):36S-40S; discussion 40S-43S. PubMed ID: 9127625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
    Nagahara A; Sato N
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():421-5. PubMed ID: 16363572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.